AIMS/ OBJECTIVE: Over expression of matrix degrading enzymes have been implicated in plaque destabilisation and rupture. Cathepsins associated with extracellular matrix breakdown make them intriguing suspects. The aim of the study was to analyse peripheral levels of cathepsin B and cathepsin K and their inhibitor cystatin C during acute myocardial infarction (AMI). MATERIALS AND METHODS: Study population included AMI patients at acute event (AMI group, n=48), stable angina patients (stable angina group n = 17), and healthy individuals (Control group, n=31). Cathepsin B, cathepsin K, cystatin C, and matrix metalloproteinases (MMP)-9 were analysed by enzyme-linked immunosorbent assay (ELISA) method. RESULTS: Cathepsin B (45.9%) and cathepsin K (92.31%) at acute event of myocardial infarction (AMI group) increased (P=0.001) while cystatin C decreased marginally (12.5%) as compared to controls. Stable angina group, demonstrated only marginal reduction in all the parameters studied as compared to controls. CONCLUSION: Cathepsin B and cathepsin K can be further evaluated as biomarkers in identifying high-risk individuals for AMI.
AIMS/ OBJECTIVE: Over expression of matrix degrading enzymes have been implicated in plaque destabilisation and rupture. Cathepsins associated with extracellular matrix breakdown make them intriguing suspects. The aim of the study was to analyse peripheral levels of cathepsin B and cathepsin K and their inhibitor cystatin C during acute myocardial infarction (AMI). MATERIALS AND METHODS: Study population included AMI patients at acute event (AMI group, n=48), stable anginapatients (stable angina group n = 17), and healthy individuals (Control group, n=31). Cathepsin B, cathepsin K, cystatin C, and matrix metalloproteinases (MMP)-9 were analysed by enzyme-linked immunosorbent assay (ELISA) method. RESULTS:Cathepsin B (45.9%) and cathepsin K (92.31%) at acute event of myocardial infarction (AMI group) increased (P=0.001) while cystatin C decreased marginally (12.5%) as compared to controls. Stable angina group, demonstrated only marginal reduction in all the parameters studied as compared to controls. CONCLUSION:Cathepsin B and cathepsin K can be further evaluated as biomarkers in identifying high-risk individuals for AMI.
Authors: Fernando Vivanco; Jose L Martín-Ventura; Mari Carmen Duran; Maria G Barderas; Luis Blanco-Colio; Verónica M Dardé; Sebastián Mas; Olivier Meilhac; Jean B Michel; Jose Tuñón; Jesús Egido Journal: J Proteome Res Date: 2005 Jul-Aug Impact factor: 4.466
Authors: G P Shi; G K Sukhova; A Grubb; A Ducharme; L H Rhode; R T Lee; P M Ridker; P Libby; H A Chapman Journal: J Clin Invest Date: 1999-11 Impact factor: 14.808
Authors: Jiqiu Chen; Ching-Hsuan Tung; Umar Mahmood; Vasilis Ntziachristos; Robert Gyurko; Mark C Fishman; Paul L Huang; Ralph Weissleder Journal: Circulation Date: 2002-06-11 Impact factor: 29.690
Authors: Sofia Jormsjö; Dirk M Wuttge; Allan Sirsjö; Carl Whatling; Anders Hamsten; Sten Stemme; Per Eriksson Journal: Am J Pathol Date: 2002-09 Impact factor: 4.307
Authors: Vinod K Shah; Kavita K Shalia; Manoj R Mashru; Surendra L Soneji; Ajin Abraham; Ketki V Kudalkar; Jagdish B Vasvani; Snehal T Sanghavi Journal: Indian Heart J Date: 2009 Jan-Feb